BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 30156548)

  • 1. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting lymphoma development in patients with Sjögren's syndrome.
    De Vita S; Gandolfo S
    Expert Rev Clin Immunol; 2019 Sep; 15(9):929-938. PubMed ID: 31347413
    [No Abstract]   [Full Text] [Related]  

  • 3. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongue Atrophy in Sjögren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands?
    Zampeli E; Kalogirou EM; Piperi E; Mavragani CP; Moutsopoulos HM
    J Rheumatol; 2018 Nov; 45(11):1565-1571. PubMed ID: 30008454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    Quartuccio L; Baldini C; Priori R; Bartoloni E; Carubbi F; Alunno A; Gandolfo S; Colafrancesco S; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S;
    J Rheumatol; 2017 Aug; 44(8):1179-1183. PubMed ID: 28507188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
    De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
    Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
    Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
    Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma in Sjögren's syndrome. From histopathology to molecular pathology.
    Jordan RC; Speight PM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Mar; 81(3):308-20. PubMed ID: 8653465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
    Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of salivary gland histopathology in primary Sjögren's syndrome: promises and pitfalls.
    Kroese FGM; Haacke EA; Bombardieri M
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):222-233. PubMed ID: 30156550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma.
    Pontarini E; Murray-Brown WJ; Croia C; Lucchesi D; Conway J; Rivellese F; Fossati-Jimack L; Astorri E; Prediletto E; Corsiero E; Romana Delvecchio F; Coleby R; Gelbhardt E; Bono A; Baldini C; Puxeddu I; Ruscitti P; Giacomelli R; Barone F; Fisher B; Bowman SJ; Colafrancesco S; Priori R; Sutcliffe N; Challacombe S; Carlesso G; Tappuni A; Pitzalis C; Bombardieri M
    Ann Rheum Dis; 2020 Dec; 79(12):1588-1599. PubMed ID: 32963045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren's syndrome].
    Vasil'iev VI; Logvinenko OA; Probatova NA; Kokosadze NV; Gorodetskiĭ VR; Kovrigina AM; Kondrat'eva TT; Mitrikov BV; Gaĭduk IV; Safonova TN; Simonova MV; Radenska-Lopovok SG; Varlamova EIu
    Ter Arkh; 2009; 81(6):20-7. PubMed ID: 19663187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical picture, outcome and predictive factors of lymphoma in primary Sjögren's syndrome: results from a harmonized dataset (1981-2021).
    Chatzis LG; Stergiou IE; Goules AV; Pezoulas V; Tsourouflis G; Fotiadis D; Tzioufas AG; Voulgarelis M
    Rheumatology (Oxford); 2022 Aug; 61(9):3576-3585. PubMed ID: 34940812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.
    Haacke EA; van der Vegt B; Vissink A; Spijkervet FKL; Bootsma H; Kroese FGM
    Ann Rheum Dis; 2017 Oct; 76(10):1781-1784. PubMed ID: 28710097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
    Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
    Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
    Van Mello NM; Pillemer SR; Tak PP; Sankar V
    Ann Rheum Dis; 2005 Mar; 64(3):471-3. PubMed ID: 15708896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MALT-lymphomas in Sjogren's disease].
    Vasil'ev VI; Probatova NA; Tupitsin NN; Varlamova EIu; Logvinenko OA; Rodionova EB; Kovrigina AM; Kokosadze NV; Panin MG; Gaĭduk IV; Gorbunova TV; Kondrat'eva TT; Sholokhova EN; Simonova MV; Safonova TN; Radenska-Lopovok SG
    Ter Arkh; 2006; 78(1):45-52. PubMed ID: 16512445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
    Baldini C; Santini E; Rossi C; Donati V; Solini A
    J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.